Moderna
MRNA
#1080
Rank
S$23.91 B
Marketcap
$62.15
Share price
-6.86%
Change (1 day)
-34.80%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -S$5.86 Billion

According to Moderna 's latest financial reports the company's current earnings are S$4.98 Billion. In 2023 the company made an earning of -S$5.19 Billion a decrease over its 2022 earnings that were of S$12.74 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -S$5.86 Billion12.93%
2023 -S$5.19 Billion-140.65%
2022 S$12.74 B-27.81%
2021 S$17.65 B-1911.15%
2020 -S$0.98 Billion44.7%
2019 -S$0.68 Billion28.63%
2018 -S$0.53 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$46.46 Million-99.19%๐Ÿ‡บ๐Ÿ‡ธ USA
S$21.88 B-483.13%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$55.43 Million-99.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.25 Billion-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA
S$16.89 B-395.82%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-S$0.7 Billion-87.79%๐Ÿ‡บ๐Ÿ‡ธ USA
S$24.41 B-527.39%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.16 Billion-97.27%๐Ÿ‡บ๐Ÿ‡ธ USA